Interventional cardiology in a whole new light

Open menu

News & Events

Visit Opsens at TCT 2019

4 September 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at TCT 2019 (Transcatheter Cardiovascular Therapeutics 2019) by attending Opsens’ complimentary lunch  and educational symposium. Register Now! The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat your patients with…

Read more

OPSENS – Q3 2019 – RECORD QUARTERLY FFR REVENUES OF $5.2 M, UP 49%

11 July 2019

Quebec City, Quebec, July 11, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the third quarter of 2019. Highlights Consolidated revenues of $7.9 M for the third quarter of 2019 compared with $6.4 M for the third quarter of 2018, an increase of $1.5 M or 23%; Fractional…

Read more

Visit Opsens at CVI 2019

2 July 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at CVI 2019 (Cardiovascular Innovations 2019) by attending Opsens’ complimentary lunch  and educational symposium. Register Now! The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat your patients with…

Read more

Learn from coronary physiology KOLs after EuroPCR 2019

30 June 2019
EuroPCR 2019 - Emanuele Barbota EuroPCR 2019 - Morton J Kern

OPSENS SOLUTIONS PARTNERS WITH TEMAI INGENIEROS FOR THE COMMISSIONING OF AN OPTICAL-BASED FUEL MONITORING SYSTEM FOR A MAJOR AIRCRAFT MANUFACTURER

17 June 2019

Paris – Le Bourget, France, June 17, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today announced that Opsens Solutions Inc. (“Opsens Solutions”), its wholly-owned subsidiary, is partnering with Temai Ingenieros S.L.  (“Temai”) for the commissioning of an optical-based fuel monitoring system for a major aircraft manufacturer. This agreement comes after over a…

Read more

OPSENS SOLUTIONS FURTHER EXPANDS INTELLECTUAL PROPERTY PORTFOLIO WITH USPTO GRANT

11 June 2019

Quebec City, Quebec, June 11, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today announced that its wholly-owned subsidiary Opsens Solutions Inc. (“Opsens Solutions”), has been granted a patent for an innovative optical-based pressure sensor from the United States Patent and Trademark Office (“USPTO”). Patent no. 10,082,437 entitled “Optical Pressure Sensor with Reduced…

Read more

Visit Opsens Solutions at the SIAE Le Bourget 2019

7 June 2019

Opsens Solutions will be exhibiting at the SIAE Le Bourget 2019, the International Paris Airshow, in France from June 17-23. Please come to visit us at booth C80, Hall 3

OPSENS TO PRESENT AT THE LD MICRO INVITATIONAL

22 May 2019

Quebec City, Quebec, May 22, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a company focusing mainly on physiological measurements such as Fractional Flow Reserve (“FFR”) and Diastolic Pressure Ratio (“dPR”) in interventional cardiology, will present at the LD Micro 9th Invitational investor conference on Tuesday, June 4, 2019 at 8:40 am PST. Louis Laflamme, Opsens’…

Read more

Visit Opsens at C3 2019

10 May 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at the C3 2019 Conference by attending Opsens’ complimentary lunch  and educational symposium.  The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat your patients with confidence. Opsens second…

Read more

Visit Opsens at EuroPCR 2019

10 May 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at EuroPCR 2019 by attending Opsens’ complimentary Case-In-Point session or visit Opsens at the exhibition: Booth #64, level 2. The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat your patients with…

Read more